Our VP, Lindsay Bealor Greenleaf, talks with Sarah Karlin-Smith about HHS’s OIG opinion on Novartis’ CAR-T

Health Policy & Access Strategy

March 26, 2021

Our VP, Lindsay Bealor Greenleaf, talks with Sarah Karlin-Smith about HHS’s OIG opinion on Novartis’ CAR-T

Read the  article here.


Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.